{
  "docId": "019de515-2650-74cb-9fbb-ccf0b0d544bc",
  "docSlug": "981e5f20a4d49416ef854962316e3684",
  "documentTitle": "Avantor | Investor Conference Presentation Deck | 18 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 18,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "kpi_overview",
  "function": "frame_situation",
  "density": "dense",
  "nDataPoints": 5,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de515-2650-74cb-9fbb-ccf0b0d544bc/8",
  "deckHref": "/decks/019de515-2650-74cb-9fbb-ccf0b0d544bc",
  "deckJsonHref": "/decks/019de515-2650-74cb-9fbb-ccf0b0d544bc.json",
  "deckAnchorHref": "/decks/019de515-2650-74cb-9fbb-ccf0b0d544bc#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.26,
        "x": 0.378,
        "y": 0.43
      },
      "kind": "list",
      "text": "EXPANSION\nInitiated 14 expansion projects³\nInvested in digital architecture\nAchieved significant renewal and expansion milestones with top 10 customers",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "04341cee-641d-4282-94d9-6483ab53f501",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.26,
        "x": 0.084,
        "y": 0.43
      },
      "kind": "list",
      "text": "INNOVATION\n3X bioproduction revenue from NPIs\nSpecified in 85% of top 20 biologics2\nCollaboration agreements with Agilent, Cytovance Biologics, GeminiBio and Oxford Nanopore",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e2b3931-9a27-4e5d-b2a7-b57b1f1c77d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.26,
        "x": 0.672,
        "y": 0.43
      },
      "kind": "list",
      "text": "M&A\nIntegrated Masterflex, Ritter, RIM Bio\nRobust NPI pipeline for 2023\nActively building M&A pipeline in focus areas",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fff1a89e-d130-4da8-b188-63d059405c58",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.506,
        "x": 0.216,
        "y": 0.916
      },
      "kind": "source-note",
      "text": "Note: NPI = New Product Introductions\n1. Represents growth in total bioproduction revenues from NPIs from 2020 to 2022E.\n2. 2022 data from Evaluate Pharma.\n3. Manufacturing and distribution expansions in 2022.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e4024ed7-fccc-4633-9cfe-a74f70845200",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.36,
        "x": 0.031,
        "y": 0.06
      },
      "kind": "title",
      "text": "Positioned for growth",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "601fade4-5ba2-443e-bab8-50e12d0f6cff",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}